Clinical Trial Update: Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating NMDA enhancers for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• NMDA enhancers

Snippet

Sponsor: Chang-Hua Hospital | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED